{"id":515457,"date":"2021-07-21T03:20:05","date_gmt":"2021-07-21T07:20:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/"},"modified":"2021-07-21T03:20:05","modified_gmt":"2021-07-21T07:20:05","slug":"ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/","title":{"rendered":"Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc."},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n MILWAUKEE<\/span>, July 21, 2021<\/span> \/PRNewswire\/ — Ademi LLP is investigating possible securities fraud claims against Ardelyx (Nasdaq: ARDX).\u00a0The investigation results from inaccurate statements Ardelyx may have made regarding its business operations and prospects.<\/p>\n

Click here to learn more about the investigation: https:\/\/www.ademilaw.com\/case\/ardelyx-inc<\/a> or call Guri Ademi<\/span> toll-free at 866-264-3995. There is no cost or obligation to you. <\/p>\n

The investigation focuses on whether Ardelyx properly disclosed the size of the treatment effect and its clinical relevance with respect to Ardelyx’s\u00a0clinical trial for tenapanor, used in the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. <\/p>\n

If you wish to obtain additional information or have information about this investigation, please contact Guri Ademi<\/span> either at gademi@ademilaw.com<\/a> or toll-free: 866-264-3995, https:\/\/www.ademilaw.com\/case\/ardelyx-inc<\/a>.\u00a0<\/p>\n

We specialize in securities fraud and shareholder litigation.\u00a0Please call us for more information.\u00a0Attorney advertising. Prior results do not guarantee similar outcomes. <\/p>\n

Contact:
Ademi LLP
Guri Ademi<\/span>
3620 East Layton Ave.
Cudahy, WI<\/span> 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001
www.ademilaw.com<\/a>\u00a0<\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc-301338214.html<\/a><\/p>\n

SOURCE Ademi LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire MILWAUKEE, July 21, 2021 \/PRNewswire\/ — Ademi LLP is investigating possible securities fraud claims against Ardelyx (Nasdaq: ARDX).\u00a0The investigation results from inaccurate statements Ardelyx may have made regarding its business operations and prospects. Click here to learn more about the investigation: https:\/\/www.ademilaw.com\/case\/ardelyx-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. The investigation focuses on whether Ardelyx properly disclosed the size of the treatment effect and its clinical relevance with respect to Ardelyx’s\u00a0clinical trial for tenapanor, used in the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. If you wish to obtain additional information or have information about this investigation, please contact Guri Ademi either at gademi@ademilaw.com … <\/p>\n

Continue reading “Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc.”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-515457","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAdemi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire MILWAUKEE, July 21, 2021 \/PRNewswire\/ — Ademi LLP is investigating possible securities fraud claims against Ardelyx (Nasdaq: ARDX).\u00a0The investigation results from inaccurate statements Ardelyx may have made regarding its business operations and prospects. Click here to learn more about the investigation: https:\/\/www.ademilaw.com\/case\/ardelyx-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. The investigation focuses on whether Ardelyx properly disclosed the size of the treatment effect and its clinical relevance with respect to Ardelyx’s\u00a0clinical trial for tenapanor, used in the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. If you wish to obtain additional information or have information about this investigation, please contact Guri Ademi either at gademi@ademilaw.com … Continue reading "Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc."\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-21T07:20:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG50156&sd=2021-07-21\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc.\",\"datePublished\":\"2021-07-21T07:20:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/\"},\"wordCount\":202,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CG50156&sd=2021-07-21\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/\",\"name\":\"Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CG50156&sd=2021-07-21\",\"datePublished\":\"2021-07-21T07:20:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CG50156&sd=2021-07-21\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CG50156&sd=2021-07-21\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/","og_locale":"en_US","og_type":"article","og_title":"Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc. - Market Newsdesk","og_description":"PR Newswire MILWAUKEE, July 21, 2021 \/PRNewswire\/ — Ademi LLP is investigating possible securities fraud claims against Ardelyx (Nasdaq: ARDX).\u00a0The investigation results from inaccurate statements Ardelyx may have made regarding its business operations and prospects. Click here to learn more about the investigation: https:\/\/www.ademilaw.com\/case\/ardelyx-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. The investigation focuses on whether Ardelyx properly disclosed the size of the treatment effect and its clinical relevance with respect to Ardelyx’s\u00a0clinical trial for tenapanor, used in the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. If you wish to obtain additional information or have information about this investigation, please contact Guri Ademi either at gademi@ademilaw.com … Continue reading \"Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-21T07:20:05+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG50156&sd=2021-07-21","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc.","datePublished":"2021-07-21T07:20:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/"},"wordCount":202,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG50156&sd=2021-07-21","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/","name":"Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG50156&sd=2021-07-21","datePublished":"2021-07-21T07:20:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG50156&sd=2021-07-21","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG50156&sd=2021-07-21"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ademi-llp-investigates-claims-of-securities-fraud-against-ardelyx-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ademi LLP Investigates Claims of Securities Fraud against Ardelyx, Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=515457"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515457\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=515457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=515457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=515457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}